BRUIN‑CLL 313 trial design

Sam prompts and Kareen details pirtobrutinib versus bendamustine‑rituximab design, crossover, and population.

Play episode from 04:54

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!